New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 14, 2014
07:33 EDTDSCIDerma Sciences reports Q4 EPS (31c), consensus (36c)
Reports Q4 revenue $20.7M, consensus $21.26M. The company said, "The increase in net loss was principally due to higher growth related selling, general and administrative expenses including higher stock-based compensation and legal expenses and taxes."
News For DSCI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 25, 2015
08:37 EDTDSCIDerma Sciences announces publication in ‘Advances in Wound Care’
Subscribe for More Information
June 18, 2015
07:30 EDTDSCIDerma Sciences says completes non-clinical aclerastide toxicology program
Subscribe for More Information
June 17, 2015
07:35 EDTDSCIDerma Sciences says Medicare coverage reinstated for Medihoney products
Derma Sciences announces that the Centers for Medicare & Medicaid Services has reinstated coverage and assigned a reimbursable code for MEDIHONEY dressings effective immediately. Additionally, the four Medicare Administrative Contractors that handle durable medical equipment issued policy adjustments over the last week. Importantly, the January 22, 2015 policy article, which introduced a new coverage standard and was the basis of the MEDIHONEY products’ coding change from covered to non-covered codes, has been rescinded effective June 12, 2015. An amended policy article, adopted by all four DME MACs and effective October 1, 2015, specifically confirms that coverage of multi-component dressings that contain medicinal honey will be based on the underlying covered components.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use